Doctors working with patients with Alzheimer’s and other causes of dementia must ask: Who will take part in your care?

A mathematical model simulated patient outcomes when given caregiver support or an expensive Alzheimer’s drug to determine cost and health benefits.

A UCSF study found that a "collaborative care" model for dementia patients improved quality of life, reduced costs, alleviated caregiver burden, and extended the time that patients remained in the ...

The US Food and Drug Administration (FDA) has approved a new version of an Alzheimer’s disease drug that can be given as a quick at-home weekly injection, offering patients a far more convenient ...

It felt like a reunion, as I greeted Mrs. S through the screen — she was the first patient of my new telehealth clinic focused on Alzheimer’s care. I had first seen her in my brick-and-mortar clinic ...

Programs that match caregivers with patient navigators yield better outcomes than Alzheimer's drug – but combining the two ...

Interim HealthCare will introduce an extensive care initiative and participate in the 2025 Alzheimer’s Association Walk to End Alzheimer’s to raise awareness and research funds SUNRISE, ...

Patients with dementia who participated in a Medicare-funded collaborative care program that provided support and medical advice for caregivers were able to remain in their home communities longer ...

Experts at a roundtable in Boston, Massachusetts, on November 3, 2025, discussed improving early Alzheimer disease diagnosis, addressing workforce and equity gaps, and expanding access to new ...

Researchers at Washington University School of Medicine in St. Louis analyzed how long 282 Alzheimer’s patients were able to continue living independently after taking two specific treatments: ...

Clinicians and health system leaders met in Portland, Oregon, on October 21, 2025, to discuss the evolving options for treating Alzheimer disease and multiple sclerosis. The first speaker, Darla ...